Edward M. Basile, Director at TransMedics Group, Inc. (TMDX), sold 14,314 shares at $86.83 ($1.2M) on 2024-02-06, disclosed to the SEC on 2024-02-08.
Scheduled sale ($1.2M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $86.27 | 5,773 | $498K | 40.3% |
| 2 | $86.27 | 5,773 | $498K | 40.3% |
| 3 | $86.83 | 1,384 | $120K | 9.7% |
| 4 | $86.83 | 1,384 | $120K | 9.7% |
| Total | $86.38 avg | 14,314 | $1.2M | 100% |
| Filing → |
| TMDX | SELL | 2025-05-29 | $632K | — | Filing → |
| TMDX | SELL | 2025-05-13 | $694K | — | Filing → |
| TMDX | SELL | 2024-11-07 | $1.1M | — | Filing → |